Posts Tagged ‘ erosion ’

Suffering in Silence: Thousands of Canadian Women and Cherie Storozinski

May 3rd, 2013 | By
Suffering in Silence: Thousands of Canadian Women and Cherie Storozinski

May 3, 2013~  “My name is Cherie Storozinski. I am 50 years old and live in Dauphin, Manitoba, Canada. I am a victim of transvagnial mesh.” That’s how Cherie started her email to MDND. Cherie, 50, had a wonderful life in rural Manitoba, Canada. She and her husband, Curt, live on 20 acres and run
[continue reading...]



FDA: Stress Urinary Incontinence (SUI) Surgical Mesh Reports up 36 Percent

Mar 29th, 2013 | By
FDA: Stress Urinary Incontinence (SUI) Surgical Mesh Reports up 36 Percent

March 29, 2013 ~ In September 2011, the U.S. Food and Drug Administration convened a panel of experts to try and get a handle on the concerning number of complications the agency was receiving about surgical mesh used to treat pelvic organ prolapse (POP)  and stress urinary incontinence (SUI).  The experts  suggested that because of the
[continue reading...]



Some Thoughts on Mesh: Product Design & Development

Mar 6th, 2013 | By
Some Thoughts on Mesh: Product Design & Development

~March 1, 2013 I helped Adam Slater as an expert with what became Gross v Ethicon from early in 2009. My job was to help Mr. Slater make sure Ethicon had produced all its relevant documents. I have the qualifications to do that because I am a veteran researcher and have run product development for
[continue reading...]



Day 17 Linda Gross v. Ethicon: Complication Rate Was Known and Acceptable says Medical Director

Feb 5th, 2013 | By
Day 17 Linda Gross v. Ethicon:  Complication Rate Was Known and Acceptable says Medical Director

Thanks go out to Courtroom View Network for access to this trial. February 5, 2013 ~ On this Day 17 as the Linda Gross v. Ethicon trial plaintiff presentation wraps up, the  former Medical Director for Ethicon Women’s Health and Urology (Gynecare) was brought to the stand via his videotaped presentation. David Robinson was involved
[continue reading...]



Day 15: Linda Gross v. Ethicon, Scientist Dismissive Over Transvaginal Mesh Complications

Feb 1st, 2013 | By
Day 15: Linda Gross v. Ethicon, Scientist Dismissive Over Transvaginal Mesh Complications

  February 1, 2013~ As the plaintiff’s case wraps up in the Linda Gross v. Ethicon trial, the deposition of the Medical Affairs Director of Ethicon (Johnson & Johnson) Europe appeared to jurors via his taped deposition. Dr. Axel Arnaud seemed dismissive of the questions asked by plaintiff attorney Adam Slater. At times his thick
[continue reading...]



Day 7: Gross v Ethicon, Discredit the Expert

Jan 18th, 2013 | By
Day 7: Gross v Ethicon, Discredit the Expert

January 18, 2013 ~ Thanks again to Courtroom View Network (CVN) for the courtroom access and images. Dr. Anne Weber was qualified as an expert witness for plaintiff Linda Gross on Thursday. Friday, January 18, was Day 7 of the trial of  Linda Gross v Ethicon in Superior Court of New Jersey. The trial is
[continue reading...]



Gross v Ethicon: Day 6 Expert Says Company Failed to Warn Doctors

Jan 17th, 2013 | By
Gross v Ethicon: Day 6 Expert Says Company Failed to Warn Doctors

January 17, 2013 ~ Thanks goes out to Courtroom View Network for access to the first Ethicon New Jersey mesh trial.   A defective product case can include defective warnings, the focus of today’s testimony. The case is expected to continue for at least one month. There are close to 2,000 other plaintiffs in this jurisdiction
[continue reading...]



Day 5: Linda Gross v Ethicon: Company Docs Show Doubts Before Prolift Launch

Jan 16th, 2013 | By
Day 5: Linda Gross v Ethicon: Company Docs Show Doubts Before Prolift Launch

January 16, 2013 ~ The worldwide medical director of Ethicon took the stand all day in the trial of Linda Gross v Ethicon in an Atlantic City courtroom. The past president of the Flemish Society of Obstetrics and Gynecology from 2007 to 2008, Piet Hinoul had become the Director of Medical Affairs at Ethicon, a
[continue reading...]



Day Two Ethicon Trial: What J&J Knew About Transvaginal Mesh and When

Jan 13th, 2013 | By
Day Two Ethicon Trial: What J&J  Knew About Transvaginal Mesh and When

January 12~ 2012 Thanks to Courtroom View Network for providing a live feed to MDND. Day two of Linda Gross v Ethicon trial in an Atlantic City court brought an Ethicon engineer to the stand who was presented with a mountain of internal company documents intended to show how safety and efficacy of the Prolift
[continue reading...]



Day One: Linda Gross v. Ethicon over Transvaginal Mesh

Jan 10th, 2013 | By
Day One: Linda Gross v. Ethicon over Transvaginal Mesh

January 10, 2013 ~ Johnson & Johnson was on the defense this afternoon in the trial of a South Dakota woman who claims she is in perpetual pain due to defective transvaginal mesh (TVM). Linda Gross, 47, from Watertown, South Dakota is represented by New Jersey-based attorney Adam Slater in the first of more than
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.